Viewing Study NCT00093704

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 9:09 PM
Ignite Modification Date: 2025-12-30 @ 12:00 AM
Study NCT ID: NCT00093704
Status: TERMINATED
Last Update Posted: 2020-07-31
First Post: 2004-10-06
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Bortezomib and Ganciclovir in Treating Patients With Relapsed or Refractory Epstein Barr Virus-Positive Lymphoma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphoma View
None Lymphoproliferative Disorder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None recurrent adult Hodgkin lymphoma View
None recurrent adult Burkitt lymphoma View
None post-transplant lymphoproliferative disorder View
None recurrent adult grade III lymphomatoid granulomatosis View
None angioimmunoblastic T-cell lymphoma View
None adult grade III lymphomatoid granulomatosis View